Generic Name and Formulations:
Edaravone 30mg/100mL; soln for IV infusion; contain sulfites.
Mitsubishi Tanabe Pharma America
Indications for RADICAVA:
Amyotrophic lateral sclerosis (ALS).
Give as IV infusion over 60mins. Initial cycle: 60mg (given as two consecutive 30mg infusions) daily for 14 days, followed by 14 days off. Subsequent cycles: 60mg daily for 10 days out of 14-day periods, followed by 14 days off.
Monitor for hypersensitivity reactions; discontinue and treat if occur. Asthma. Sulfite sensitivity. Pregnancy. Nursing mothers.
Free radical scavenger.
Confusion, gait disturbance, headache, dermatitis, eczema, respiratory failure/disorders, hypoxia, glycosuria, tinea infection; hypersensitivity reactions, anaphylaxis.
Single-dose bags—1, 2
Clinical Pain Advisor Articles
- Brain Plasticity in Patients With Complex Regional Pain Syndrome
- Chronic Pain Associated With Traumatic Brain Injury: Causes and Management
- Perturbation-Based Rehabilitation Effective for Chronic Low Back Pain
- Migraine Frequency Correlated With Depression and Anxiety
- IBS-Associated Chronic Pain: Formulation of Core Diagnostic Criteria
- Cannabis Use Associated With Aberrant Drug Behaviors
- Walgreens to Carry Naloxone in All Pharmacies to Combat Drug Abuse
- Independent Pharmacies Expanding Services Available to Patients
- Ketamine Exhibits Effective Pain Relief for Refractory Headaches
- Pain In Elite Athletes: IOC Recommendations on Contributing Factors and Treatment Approach
- Naproxen Plus Muscle Relaxants vs Naproxen Monotherapy for Low Back Pain
- Pain Processing: Examining the Role of Oxytocin
- Short- vs Long-Acting Opioids for Osteoarthritis Pain
- Extended-Release Naltrexone Injections Reduce Opioid Dependence
- Depressive Symptoms in Medical Interns Increased With Work-Family Conflicts